Regulation of Nerve Injury-induced Gene Expression in Neuropathic Pain
神经病理性疼痛中神经损伤诱导的基因表达的调节
基本信息
- 批准号:10188652
- 负责人:
- 金额:$ 34.67万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-07-01 至 2023-06-30
- 项目状态:已结题
- 来源:
- 关键词:AdultAfferent NeuronsAmplifiersAnimalsAntibodiesB-Cell LymphomasBindingBiochemical ProcessCSF1 geneCSF1R geneCellsDataDevelopmentDiabetic NeuropathiesEconomic BurdenEmbryoEmbryonic DevelopmentEpigenetic ProcessFemaleGene ExpressionGenesGenetic TranscriptionHistonesHourHypersensitivityImmunohistochemistryImpairmentInjuryIntrathecal InjectionsKnock-outLocal AnestheticsMacrophage Colony-Stimulating FactorMalignant NeoplasmsMechanicsMicrogliaMolecular TargetMotor NeuronsMusNeuronsOperative Surgical ProceduresPerioperativePersistent painPhenotypePostoperative PainPreemptive AnalgesiaProcessQuality of lifeQuantitative Reverse Transcriptase PCRRegulationReverse Transcriptase Polymerase Chain ReactionSensory GangliaSeriesSignal TransductionSpinal CordSpinal GangliaSurgical InjuriesTechniquesTestingTimeTissuesTraumaTraumatic Nerve InjuryUp-Regulationbasec-myc Geneschromatin immunoprecipitationcytokineepigenetic markerepigenetic regulationexperimental studygene inductiongenome browserinhibitor/antagonistinjuredmacrophagemalemouse modelnerve injuryneutralizing antibodypain behaviorpainful neuropathypost-traumapreemptive interventionpreventpromoterrecruitsciatic nervetranscription factor
项目摘要
Abstract
Nerve injury-induced neuropathic pain following surgery or trauma has a significant economic burden that
impairs quality of life. Despite the identification of a host of molecular targets implicated in the development of
neuropathic pain, post-surgical and post-trauma neuropathic pains are often intractable. Unlike other
neuropathic pain conditions, such as diabetic neuropathy, the time that nerve injury occurs during surgery or
following trauma is well defined. As a result, it is possible that a pre-emptive intervention, either during the
perioperative period or shortly after the trauma, could prevent the development of persistent pain. Indeed, local
anesthetic based pre-emptive analgesia techniques have been developed. However, although these
techniques are very good in managing immediate post-surgical pain, they only offer limited long-term benefit.
In a mouse model of neuropathic pain in which the sciatic nerve is surgically injured, we recently demonstrated
a critical contribution of injury-induced de novo synthesis and release of the cytokine, colony stimulating factor
1 (CSF1, also known as macrophage colony stimulating factor) from dorsal root ganglion (DRG) sensory
neurons. Our studies established that CSF1 is both necessary and sufficient for nerve injury-induced activation
of spinal cord microglia, the tissue macrophages of the CNS, and for post-injury mechanical hypersensitivity/
neuropathic pain behavior. Here, in Specific Aims 1 and 2, we propose experiments that will first define the
transcriptional mechanism that triggers CSF1 induction in injured DRG neurons. Our preliminary analysis of the
Santa Cruz Genome Browser ChIP-Seq data from B-cell lymphoma revealed 19 transcription factors that bind
to CSF1 promoter. Among these 19 genes, using quantitative RT-PCR we determined that c-Myc is also
induced in DRG after nerve injury. Interestingly, the c-Myc induction occurred within hours of nerve injury, well
before the induction of CSF1. Immunohistochemistry confirmed the induction of c-Myc and its co-expression
with CSF1 in DRG neurons. Of note, c-Myc is a universal amplifier of gene expression in cancer and
embryonic development, but its function in adult non-proliferating cells is largely unknown. More importantly,
pre-emptive local anesthetic treatment of sciatic nerve prior to the injury did not prevent the induction of c-Myc
in DRG neurons, indicating that its induction is not activity dependent. Based on these findings, we
hypothesize that c-Myc is a major contributor to CSF1 gene induction in the injured DRG neurons, and that
targeting c-Myc might prevent the CSF1 gene induction and thus prevent neuropathic pain development.
Finally, as the expression of CSF1 persists for weeks after nerve injury, we will also test the hypothesis that
CSF1 not only contributes to the initiation of the neuropathic pain phenotype, but also to its persistence. Thus
in Specific Aim 3, we will delete or block CSF1 from DRG neurons after injury occurs. Finally, given recent
evidence for differences in microglial contribution to the neuropathic pain phenotype in male and female mice,
our studies will also assess the contribution of these mechanisms both in male and female mice.
抽象的
手术或创伤后神经损伤引起的神经性疼痛会带来巨大的经济负担
损害生活质量。尽管鉴定了许多与发展相关的分子靶标
神经性疼痛、手术后和创伤后神经性疼痛通常是顽固性的。与其他不同
神经性疼痛,例如糖尿病性神经病、手术期间发生神经损伤的时间或
创伤后的定义是明确的。因此,先发制人的干预是可能的,无论是在
围手术期或创伤后不久,可以防止持续性疼痛的发展。确实,本地
基于麻醉的超前镇痛技术已经开发出来。然而,尽管这些
这些技术对于控制术后立即疼痛非常有效,但它们只能提供有限的长期益处。
在坐骨神经受到手术损伤的神经性疼痛小鼠模型中,我们最近证明
损伤诱导的细胞因子、集落刺激因子的从头合成和释放的关键贡献
1(CSF1,也称为巨噬细胞集落刺激因子),来自背根神经节 (DRG) 感觉
神经元。我们的研究证实 CSF1 对于神经损伤诱导的激活既是必要的也是充分的
脊髓小胶质细胞、中枢神经系统组织巨噬细胞以及损伤后机械超敏反应/
神经性疼痛行为。在这里,在具体目标 1 和 2 中,我们提出实验,首先定义
在受伤的 DRG 神经元中触发 CSF1 诱导的转录机制。我们初步分析
Santa Cruz Genome Browser 来自 B 细胞淋巴瘤的 ChIP-Seq 数据揭示了 19 种结合的转录因子
至 CSF1 启动子。在这 19 个基因中,使用定量 RT-PCR,我们确定 c-Myc 也是
神经损伤后在 DRG 中诱导。有趣的是,c-Myc 诱导发生在神经损伤后数小时内,
在诱导 CSF1 之前。免疫组织化学证实了 c-Myc 的诱导及其共表达
DRG 神经元中含有 CSF1。值得注意的是,c-Myc 是癌症和癌症中基因表达的通用放大器
胚胎发育过程中,但其在成年非增殖细胞中的功能很大程度上未知。更重要的是,
损伤前对坐骨神经进行预先局部麻醉治疗并不能阻止 c-Myc 的诱导
在 DRG 神经元中,表明其诱导不依赖于活动。基于这些发现,我们
假设 c-Myc 是损伤 DRG 神经元中 CSF1 基因诱导的主要贡献者,并且
靶向 c-Myc 可能会阻止 CSF1 基因诱导,从而阻止神经性疼痛的发展。
最后,由于 CSF1 的表达在神经损伤后持续数周,我们还将检验以下假设:
CSF1 不仅有助于神经性疼痛表型的启动,而且还有助于其持续存在。因此
在具体目标 3 中,我们将在损伤发生后从 DRG 神经元中删除或阻断 CSF1。最后,考虑到最近
小胶质细胞对雄性和雌性小鼠神经病理性疼痛表型的贡献存在差异的证据,
我们的研究还将评估这些机制在雄性和雌性小鼠中的贡献。
项目成果
期刊论文数量(11)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Modified Spared Nerve Injury Surgery Model of Neuropathic Pain in Mice.
小鼠神经性疼痛的改良保留神经损伤手术模型。
- DOI:10.3791/63362
- 发表时间:2022
- 期刊:
- 影响因子:0
- 作者:He,Liangliang;Zhao,Wenxing;Zhang,Lingyi;Ilango,Maalveka;Zhao,Na;Yang,Liqiang;Guan,Zhonghui
- 通讯作者:Guan,Zhonghui
Ion Channels in Anesthesia.
麻醉中的离子通道。
- DOI:10.1007/978-981-16-4254-8_19
- 发表时间:2021
- 期刊:
- 影响因子:0
- 作者:Zhou,Wei;Guan,Zhonghui
- 通讯作者:Guan,Zhonghui
Spinal Cord Stimulation for Failed Back Surgery Syndrome -- Patient Selection Considerations.
脊髓刺激治疗背部手术失败综合征——患者选择考虑因素。
- DOI:
- 发表时间:2019
- 期刊:
- 影响因子:0
- 作者:Palmer,Nicole;Guan,Zhonghui;Chai,NuCindy
- 通讯作者:Chai,NuCindy
Identification of Foramen Ovale With H-Figure Fluoroscopic Landmark Improves Treatment Outcomes in Idiopathic Trigeminal Neuralgia.
- DOI:10.1213/ane.0000000000005992
- 发表时间:2022-10-01
- 期刊:
- 影响因子:5.7
- 作者:
- 通讯作者:
Case Report and Literature Review: Interventional Management of Erythromelalgia.
病例报告和文献综述:红斑性肢痛症的介入治疗。
- DOI:10.31480/2330-4871/094
- 发表时间:2019
- 期刊:
- 影响因子:0
- 作者:Chinn,Gregory;Guan,Zhonghui
- 通讯作者:Guan,Zhonghui
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Zhonghui Guan其他文献
Zhonghui Guan的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Zhonghui Guan', 18)}}的其他基金
相似国自然基金
面向类脑智能感知的编码运算一体化柔性电子传入神经元的研究
- 批准号:
- 批准年份:2021
- 资助金额:60 万元
- 项目类别:面上项目
不同刺灸法激活的穴位传入神经元及时间-空间反应特性
- 批准号:81973967
- 批准年份:2019
- 资助金额:55 万元
- 项目类别:面上项目
有髓传入神经纤维相应DRG神经元中Cav3.2通道N-糖基化在DPN触诱发痛发生发展中的作用机制研究
- 批准号:81801219
- 批准年份:2018
- 资助金额:21.0 万元
- 项目类别:青年科学基金项目
通过内皮素-1探索初级传入神经元感受疼痛或搔痒的细胞机制
- 批准号:81171040
- 批准年份:2011
- 资助金额:55.0 万元
- 项目类别:面上项目
相似海外基金
REDOX PHARMACOLOGY OF T CHANNELS IN DRG NEURONS
DRG 神经元 T 通道的氧化还原药理学
- 批准号:
7942245 - 财政年份:2009
- 资助金额:
$ 34.67万 - 项目类别:
REDOX PHARMACOLOGY OF T CHANNELS IN DRG NEURONS
DRG 神经元 T 通道的氧化还原药理学
- 批准号:
7631340 - 财政年份:2006
- 资助金额:
$ 34.67万 - 项目类别:
REDOX PHARMACOLOGY OF T CHANNELS IN DRG NEURONS
DRG 神经元 T 通道的氧化还原药理学
- 批准号:
7208052 - 财政年份:2006
- 资助金额:
$ 34.67万 - 项目类别:
Integrated Interdisciplinary Training in Computational Neuroscience
计算神经科学综合跨学科培训
- 批准号:
7293610 - 财政年份:2006
- 资助金额:
$ 34.67万 - 项目类别:
REDOX PHARMACOLOGY OF T CHANNELS IN DRG NEURONS
DRG 神经元 T 通道的氧化还原药理学
- 批准号:
7439132 - 财政年份:2006
- 资助金额:
$ 34.67万 - 项目类别: